ROSEAID

Rapid on-site evaluation (ROSE) is an established procedure where a Cytopathologist evaluates a biopsy specimen at the time of collection to determine if the content is adequate to provide a diagnosis. ROSE AId, a technology that digitizes and automates the ROSE process, can increase availability of ROSE in all healthcare settings resulting in a reduction in repeat biopsies, timelier diagnosis, and ultimately better outcomes.

Also known as: Rose AId, Inc.